Human Injuries Associated with the Transport of Horses by Road.

Animals (Basel). May 2023;13(10):.

Christopher B Riley¹, Barbara Padalino², Chris W Rogers³, Kirrilly R Thompson⁴

¹ Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.; ² Dipartimento di Scienze e Tecnologie Agro-Alimentari, Alma Mater Studiorum-Università di Bologna, Viale Fanin 50, 40126 Bologna, Italy.; ³ School of Veterinary Science, Massey University, Palmerston North 4442, New Zealand.; ⁴ School of Medicine and Public Health, University of Newcastle, Newcastle, NSW 2300, Australia.

Abstract

There is an increased understanding of shared human-animal risk in terms of "one welfare", whereby when animals are at risk, so are people, so preventing injury to one species may also prevent injury to the other. Because transport-related injuries to horses are common, the authors considered this paradigm to study road equine transport-related injuries to humans in New Zealand. The aim was to determine their frequency and associated factors by distributing a survey to horse industry participants through industry organisations asking about their horse activities, road transport experiences, and any related self-injury. There were 112/1067 (10.5%) handlers injured while preparing (13/112), loading (39/112), traveling (6/112), or unloading (33/112). Of these, 40% had multiple injury types, and 33% had several body regions affected. Hand injuries were most common (46%), followed by the foot (25%), arm (17%), and head or face (15%). Median recovery time was 7 days. Injuries were associated with the responder's industry educational background, years of driving experience, and reporting a horse injured during road transport in the past two years. Wearing helmets and gloves, and adopting strategies designed to eliminate equine injuries associated with the road transport of horses to reduce the risk of injury to their handlers are recommended.

Keywords

equine; horse; human; injury; one welfare; risk; road; transport; transportation;

Article Tools:

Medline

Email to me

Archives Highlights:

Effective treatment with afoxolaner (NexGard) of Trixacarus caviae in a pet guinea pig.
The animal was treated with a single oral dose of 2.50 mg/kg afoxolaner, and the lesions, presence/absence of mites, and intensity of pruritus were evaluated periodically until 2 months post-treatment. A week after the medication, the lesions were milder, but pruritus was still present and was attributed to the healing process. Further examinations showed significant improvement with the complete remission of clinical signs and no mites at the microscopic examination after 4 weeks.

Computed tomography findings of nasal cryptococcosis in Australia (2008-2020): 12 dogs and 9 cats.
Dogs were more likely to have a nasal mass, whereas cats were more likely to have a nasopharyngeal mass. Cribriform plate lysis was common in dogs, but not observed in cats. Sinonasal osteolysis was a common feature in both species. Mandibular lymph nodes were commonly enlarged in dogs, whereas in cats, the retropharyngeal lymph nodes were more likely enlarged.

Clinical manifestations of chronic pancreatitis in English cocker spaniels.
Affected English cocker spaniels presented with a high frequency of KCS (n = 49), proteinuria (n = 47), anal gland disease (n = 36), atopy (n = 21), and other immune-mediated diseases (n = 16). Those with parti-color hair coats, particularly blue roan, had a strong association with chronic pancreatitis, suggesting a link between coat color and autoimmune conditions in this breed.

How to Address Common Misconceptions About Nutrition
Choosing the optimal food for one’s pet can evoke many emotions. Love, confusion, fear, guilt, and complacency are just some of the feelings evoked by pet food industry marketing. Navigating which concerns are valid or fabricated is challenging.

Duration of efficacy and effect of implant location in adult queens treated with a 9.4 mg deslorelin subcutaneous implant.
The average duration of action of the 9.4 mg deslorelin implant was 790 ± 155 days (range 525-1140 days) with no significant difference in duration or efficacy depending on implantation sites. The 9.4 mg deslorelin implant causes pharmacological sterilization for about 2 years in female cats, is fully reversible, and caused no clinically relevant side effects when administered at both interscapular and periumbilical sites.